Carl Barnes Heilman MD
Professor and Chair, Neurosurgery, Tufts Medical Center
Join to View Full Profile
800 Washington StTufts Medical Center, #178 NeurosurgeryBoston, MA 02111
Phone+1 617-636-5860
Fax+1 617-636-7587
Dr. Heilman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterResidency, Neurological Surgery, 1987 - 1993
St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 1986 - 1987
Perelman School of Medicine at the University of PennsylvaniaClass of 1986
Certifications & Licensure
MA State Medical License 1988 - 2027
PA State Medical License 1991 - 1992
American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
- America's Top Doctors Castle Connolly, 2007-2014
Publications & Presentations
PubMed
- First-in-Human Treatment of Medically Refractory Idiopathic Intracranial Hypertension With the eShunt System: Case Report.Pedro Lylyk, Ivan Lylyk, Carlos Bleise, Esteban Scrivano, Pedro N Lylyk
Stroke. 2026-05-01 - Safety of endovascular shunting for normal pressure hydrocephalus from a prospective, multicenter, single-arm study.Pedro Lylyk, Charles C Matouk, Ricardo A Hanel, John F Reavey-Cantwell, Howard A Riina
Journal of Neurointerventional Surgery. 2026-02-24 - 2 citationsMorphometric analysis of the inferior petrosal sinus and cerebellopontine angle cistern to assess feasibility of endovascular shunting in pediatric patients.Marco Colasurdo, Karen Chen, Huanwen Chen, Matthew K McIntyre, Charles Matouk
Journal of Neurointerventional Surgery. 2026-02-16
Authored Content
- Regression of a Nonfunctioning Pituitary Macroadenoma on the CDK4/6 Inhibitor Palbociclib: Case Report RelatedJune 2018
Press Mentions
A New Chapter in Skull Base Surgery at TuftsApril 24th, 2026- CereVasc Receives Health Canada Investigational Testing Authorization for STRIDE Clinical Trial of the eShunt® SystemJune 19th, 2025
- CereVasc, Inc. Receives FDA Breakthrough Device Designation for the eShunt® System for Use in Pediatric PatientsApril 23rd, 2025
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
